1. Home
  2. SSYS vs MLYS Comparison

SSYS vs MLYS Comparison

Compare SSYS & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

HOLD

Current Price

$9.13

Market Cap

806.5M

Sector

Technology

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$35.93

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
MLYS
Founded
1989
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
806.5M
3.1B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
SSYS
MLYS
Price
$9.13
$35.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$12.75
$46.40
AVG Volume (30 Days)
648.5K
1.7M
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$561,461,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$8.24
52 Week High
$12.88
$47.65

Technical Indicators

Market Signals
Indicator
SSYS
MLYS
Relative Strength Index (RSI) 46.93 36.67
Support Level $8.98 $35.77
Resistance Level $9.92 $39.15
Average True Range (ATR) 0.29 1.95
MACD 0.14 -0.61
Stochastic Oscillator 49.74 0.70

Price Performance

Historical Comparison
SSYS
MLYS

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: